{"groups":[{"description":"Patients receive paclitaxel IV over 3 hours or docetaxel IV over 1 hour and carboplatin over 30 minutes on day 1. Treatment repeats every 21 days. Patients are not in secondary cytoreductive surgery portion of study.","id":"FG000","title":"Arm I (no Surgery; Carboplatin and Paclitaxel)"},{"description":"Patients receive chemotherapy as in arm I and bevacizumab IV over 30-90 minutes on day 1. Treatment repeats every 21 days. Patients are not in secondary cytoreductive surgery portion of study.","id":"FG001","title":"Arm II (no Surgery; Carboplatin, Paclitaxel and Bevacizumab)"},{"description":"Patients receive paclitaxel IV over 3 hours or docetaxel IV over 1 hour and carboplatin over 30 minutes on day 1. Treatment repeats every 21 days. Patients receive secondary cytoreductive surgery.","id":"FG002","title":"Arm III (Surgery; Carboplatin and Paclitaxel)"},{"description":"Patients receive paclitaxel IV over 3 hours or docetaxel IV over 1 hour and carboplatin over 30 minutes on day 1. Treatment repeats every 21 days. Patients receive secondary cytoreductive surgery.","id":"FG003","title":"Arm IV (Surgery; Carboplatin, Paclitaxel and Bevacizumab)"},{"description":"Patients receive carboplatin as in arm I. Patients receive gemcitabine. Treatment repeats every 21 days. Patients do not receive secondary cytoreductive surgery.","id":"FG004","title":"Arm V (no Surgery; Carboplatin and Gemcitabine)"},{"description":"Patients receive carboplatin as in arm I and bevacizumab IV over 30-90 minutes on day 1. Patients receive gemcitabine. Treatment repeats every 21 days. Patients do not receive secondary cytoreductive surgery.","id":"FG005","title":"Arm VI (no Surgery; Carboplatin, Gemcitabine and Bevacizumab)"},{"description":"Patients receive carboplatin as in arm I. Patients receive gemcitabine. Treatment repeats every 21 days. Patients receive secondary cytoreductive surgery.","id":"FG006","title":"Arm VII (Surgery; Carboplatin and Gemcitabine)"},{"description":"Patients receive carboplatin as in arm I and bevacizumab IV over 30-90 minutes on day 1. Patients receive gemcitabine. Treatment repeats every 21 days. Patients receive secondary cytoreductive surgery.","id":"FG007","title":"Arm VIII (Surgery; Carboplatin, Gemcitabine and Bevacizumab)"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"316"},{"groupId":"FG001","numSubjects":"456"},{"groupId":"FG002","numSubjects":"33"},{"groupId":"FG003","numSubjects":"165"},{"groupId":"FG004","numSubjects":"6"},{"groupId":"FG005","numSubjects":"34"},{"groupId":"FG006","numSubjects":"5"},{"groupId":"FG007","numSubjects":"37"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"33"},{"groupId":"FG003","numSubjects":"165"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"5"},{"groupId":"FG007","numSubjects":"37"}],"type":"Randomized - Yes Surgery"},{"achievements":[{"groupId":"FG000","numSubjects":"33"},{"groupId":"FG001","numSubjects":"172"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"6"},{"groupId":"FG005","numSubjects":"34"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"}],"type":"Randomized - no Surgery"},{"achievements":[{"groupId":"FG000","numSubjects":"283"},{"groupId":"FG001","numSubjects":"284"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"}],"type":"Not Surgical Candidate"},{"achievements":[{"groupId":"FG000","numSubjects":"313"},{"groupId":"FG001","numSubjects":"454"},{"groupId":"FG002","numSubjects":"31"},{"groupId":"FG003","numSubjects":"154"},{"groupId":"FG004","numSubjects":"6"},{"groupId":"FG005","numSubjects":"34"},{"groupId":"FG006","numSubjects":"5"},{"groupId":"FG007","numSubjects":"35"}],"comment":"Includes participants who followed through with surgical assignment","type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"2"},{"groupId":"FG002","numSubjects":"2"},{"groupId":"FG003","numSubjects":"11"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"2"}],"type":"NOT COMPLETED"}],"title":"Surgical Assignment"},{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"9"},{"groupId":"FG001","numSubjects":"9"},{"groupId":"FG002","numSubjects":"3"},{"groupId":"FG003","numSubjects":"18"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"2"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"2"}],"type":"Never Initiated Chemotherapy"},{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"14"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"18"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"1"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"1"}],"type":"Still On Chemotherapy"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"316"},{"groupId":"FG001","numSubjects":"456"},{"groupId":"FG002","numSubjects":"33"},{"groupId":"FG003","numSubjects":"165"},{"groupId":"FG004","numSubjects":"6"},{"groupId":"FG005","numSubjects":"34"},{"groupId":"FG006","numSubjects":"5"},{"groupId":"FG007","numSubjects":"37"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"310"},{"groupId":"FG001","numSubjects":"311"},{"groupId":"FG002","numSubjects":"27"},{"groupId":"FG003","numSubjects":"26"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"}],"type":"Randomized to Chemo"},{"achievements":[{"groupId":"FG000","numSubjects":"6"},{"groupId":"FG001","numSubjects":"145"},{"groupId":"FG002","numSubjects":"6"},{"groupId":"FG003","numSubjects":"139"},{"groupId":"FG004","numSubjects":"6"},{"groupId":"FG005","numSubjects":"34"},{"groupId":"FG006","numSubjects":"5"},{"groupId":"FG007","numSubjects":"37"}],"type":"Pre-specified Chemo"},{"achievements":[{"groupId":"FG000","numSubjects":"307"},{"groupId":"FG001","numSubjects":"433"},{"groupId":"FG002","numSubjects":"30"},{"groupId":"FG003","numSubjects":"129"},{"groupId":"FG004","numSubjects":"6"},{"groupId":"FG005","numSubjects":"31"},{"groupId":"FG006","numSubjects":"5"},{"groupId":"FG007","numSubjects":"34"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"9"},{"groupId":"FG001","numSubjects":"23"},{"groupId":"FG002","numSubjects":"3"},{"groupId":"FG003","numSubjects":"36"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"3"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"3"}],"type":"NOT COMPLETED"}],"title":"Chemotherapy Assignment"}],"recruitmentDetails":"At the beginning of the study participants could be randomized to chemotherapy. On August 29, 2011 randomization to chemotherapy ended and participants could only be randomized to surgery."}